BofA Securities Initiates National Health Investors Inc(NHI.US) With Buy Rating, Announces Target Price $83
BMO Capital Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $86
National Health Investors Price Target Raised to $76.00/Share From $70.00 by Truist Securities
Truist Financial Reaffirms Their Hold Rating on National Health Investors (NHI)
National Health Investors Analyst Ratings
Wedbush Reiterates Outperform on National Health Investors, Maintains $88 Price Target
National Health Investors (NHI) Gets a Hold From Wells Fargo
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Hold Rating, Maintains Target Price $76
BMO Capital Upgrades National Health Investors Inc(NHI.US) to Buy Rating, Raises Target Price to $83
Truist Financial Maintains National Health Investors Inc(NHI.US) With Hold Rating
Analysts Offer Insights on Real Estate Companies: LTC Properties (LTC), National Health Investors (NHI) and Kkr Real Estate Finance (KREF)
BMO Capital Maintains National Health Investors Inc(NHI.US) With Buy Rating, Cuts Target Price to $85
Truist Financial Maintains National Health Investors Inc(NHI.US) With Hold Rating, Cuts Target Price to $70
Wedbush Cuts Price Target on National Health Investors to $77 From $87, Keeps Outperform Rating
National Health Investors Price Target Cut to $72.00/Share From $78.00 by Truist Securities
National Health Investors Analyst Ratings
Truist Financial Maintains National Health Investors Inc(NHI.US) With Hold Rating, Announces Target Price $72
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Hold Rating, Announces Target Price $76
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Hold Rating
BofA Securities Maintains National Health Investors Inc(NHI.US) With Buy Rating, Cuts Target Price to $91